Citi Pharma Ltd. (CPHL) Share Price – Pakistan Stock Exchange (PSX)
Citi Pharma Ltd.
CPHLPHARMACEUTICALS·8th of 14 by market cap
Prev Close77.52
Open78.40
Day Change-0.32-0.41%
Volume2.30M
YTD Return-8.75%
Day Range
76.95
78.40
52W Range
69.25
104.25
Key Metrics
RevRevenueGood
Rs. 13.15 B
ProfitNet ProfitAvg
Rs. 892.0 M
EPSEPSGood
₨3.90
ROEROEAvg
8.2%
P/EP/ELow
19.8x
YieldDiv YieldGood
4.5%
Citi Pharma Ltd. has shown positive revenue growth of 6.0% over the past year. Net income has grown by 7.1% year-over-year. The company maintains a return on equity of 8.2%.
Company Profile
About Citi Pharma Ltd.
CPHL · PHARMACEUTICALS
Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
Company Information
Key People
Rizwan AhmadCEO